首頁 > 市場調查報告書 > 製藥

疼痛

Ibuprofen原料藥市場規模、佔有率及成長分析（按應用、劑型及地區分類）－產業預測（2026-2033）

市場調查報告書

商品編碼

1917213

Ibuprofen原料藥市場規模、佔有率及成長分析（按應用、劑型及地區分類）－產業預測（2026-2033）

Ibuprofen API Market Size, Share, and Growth Analysis, By Application (Pharmaceuticals, Consumer Healthcare), By Formulation Type (Tablets, Oral), By Region - Industry Forecast 2026-2033

出版日期: 2026年01月02日 | 出版商:

SkyQuest | 英文 175 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球Ibuprofen原料藥市場規模將達到 64.6 億美元，到 2025 年將達到 67.3 億美元，到 2033 年將達到 93.6 億美元，預測期（2026-2033 年）的複合年成長率為 4.2%。

由於醫療保健服務的改善、人口老化以及學名藥的普及，全球Ibuprofen原料藥市場正經歷顯著成長。處方藥和非處方藥市場對消炎鎮痛藥的需求推動了市場擴張。影響這一趨勢的關鍵因素包括全球人口老化、醫療保健服務的改善以及價格低廉的非專利藥的日益普及。北美和歐洲佔了相當大的市場佔有率，反映出對高附加價值原料藥的穩定需求。然而，原料成本波動和監管壁壘等挑戰可能會影響企業的營運效率。儘管如此，市場前景依然樂觀，預計亞太地區將在產能和出口量方面發揮主導作用，從而引領Ibuprofen原料藥產業未來的發展趨勢。

全球Ibuprofen原料藥市場促進因素

全球Ibuprofen原料藥市場正經歷顯著成長，主要受消費者對經濟有效的止痛和抗發炎治療需求不斷成長的推動。專利到期和醫療保健成本節約措施的推動，促進了非專利藥的普及，進一步鞏固了布洛芬的市場地位。此外，人口老化導致慢性疼痛和發炎性疾病的盛行率不斷上升，也對市場規模和收入的成長起到了關鍵作用。這些因素共同創造了良好的市場環境，有利於Ibuprofen原料藥的持續研發與發展，以滿足不同消費族群的需求。

限制全球Ibuprofen原料藥市場的因素

全球Ibuprofen原料藥市場面臨許多挑戰，其中關鍵前驅物（如異丁基苯和乙醯氯）價格波動尤其顯著。這些價格波動直接影響生產成本和整體盈利，尤其對中小型生產者而言更是如此。此外，對有限供應商的依賴顯著增加了供應鏈風險，導致市場前景難以預測且波動劇烈。這種脆弱性加劇了商業環境的複雜性，使得企業在外部經濟壓力下難以維持穩定的業務營運和策略規劃。

全球Ibuprofen原料藥市場趨勢

全球Ibuprofen原料藥市場正呈現出顯著的地域多角化和近岸外包趨勢，買家尋求降低供應鏈風險。這一轉變正在重塑市場動態，亞太地區的中小型生產商不斷擴大市場佔有率並提升產能。同時，北美和歐洲市場在日益重視供應安全的背景下，需求也出現了顯著復甦。這種不斷變化的市場格局不僅影響籌資策略，也加劇了製造商之間的競爭，因為相關人員正在尋求在動盪的市場環境中建立可靠且具韌性的供應鏈。

BASF股份公司（德國）
IOL化學製藥有限公司（IOLCP）（印度）
山東新華藥業有限公司（中國）
Solara Active Pharma Sciences Limited（印度）
SIGroup Limited（美國）
瑞迪博士實驗室有限公司（印度）
印度顆粒有限公司（印度）
美國淄博新華百利高製藥有限公司 (中國)
Strides Pharma Science Limited（印度）
梯瓦製藥工業股份有限公司（以色列）
輝瑞公司（美國）
雅培實驗室（美國）
BIOCAUSE公司（美國）
Mallinckrodt製藥公司（美國）
SMS製藥有限公司（印度）
Wanbury有限公司（印度）
奧羅賓多製藥有限公司（印度）
浙江華海藥業股份有限公司（中國）
Jubilant Life Sciences Ltd.（印度）
太陽製藥工業有限公司（印度）

結論與建議

簡介目錄

Product Code: SQMIG35I2474

Global Ibuprofen API Market size was valued at USD 6.46 Billion in 2024 and is poised to grow from USD 6.73 Billion in 2025 to USD 9.36 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

The global Ibuprofen API market is experiencing notable growth driven by increased healthcare access, a growing elderly population, and the prevalent use of generic medications. The demand for anti-inflammatory and pain relief medications, both in prescription and over-the-counter segments, is propelling market expansion. Key factors influencing this trend include a worldwide aging demographic, enhanced healthcare accessibility, and greater adoption of affordable generic alternatives. North America and Europe hold significant market shares, reflecting a stable demand for high-value APIs. However, challenges like fluctuating raw material costs and regulatory hurdles may affect operational efficiency. The outlook remains optimistic as Asia Pacific is anticipated to lead in production capacity and export volume, establishing key trends for the Ibuprofen API sector going forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ibuprofen API market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ibuprofen API Market Segments Analysis

Global Ibuprofen API Market is segmented by Application, Formulation Type and region. Based on Application, the market is segmented into Pharmaceuticals, Consumer Healthcare and Animal Healthcare. Based on Formulation Type, the market is segmented into Tablets, Oral, Suspension and Topical. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Ibuprofen API Market

The Global Ibuprofen API market is experiencing significant growth driven by the rising demand for cost-effective pain relief and anti-inflammatory treatments. The proliferation of generic formulations, propelled by the expiration of patents and initiatives aimed at improving healthcare affordability, further strengthens market presence. Additionally, the aging population coupled with a higher prevalence of chronic pain conditions and inflammatory disorders is playing a crucial role in expanding the market's size and revenue. Together, these factors create a robust environment for the continuous development and advancement of Ibuprofen API offerings, meeting the needs of diverse consumer segments.

Restraints in the Global Ibuprofen API Market

The Global Ibuprofen API market faces significant challenges due to the volatility in the prices of essential precursors such as isobutyl benzene and acetyl chloride. These price fluctuations directly impact production costs and the overall profitability for manufacturers, particularly smaller and medium-sized enterprises. Furthermore, the market's reliance on a narrow range of suppliers poses considerable supply chain risks, leading to an unpredictable and unstable outlook. This vulnerability complicates the business environment, making it difficult for companies to maintain consistent operations and strategic planning in the face of external economic pressures.

Market Trends of the Global Ibuprofen API Market

The Global Ibuprofen API market is witnessing a significant trend towards regional diversification and near-shoring as buyers aim to mitigate supply chain risks. This shift is reshaping market dynamics, with small to mid-sized producers in the Asia-Pacific region boosting their presence and expanding production capabilities. Concurrently, there is a noticeable demand resurgence in North America and Europe, driven by the growing emphasis on security of supply. This evolving landscape not only influences sourcing strategies but also encourages greater competition among manufacturers, as stakeholders seek reliable and resilient supply chains in an increasingly volatile market environment.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Ibuprofen API Market Size by Application & CAGR (2026-2033)

Market Overview
Pharmaceuticals
Consumer Healthcare
Animal Healthcare

Global Ibuprofen API Market Size by Formulation Type & CAGR (2026-2033)

Market Overview
Tablets
Oral
Suspension
Topical

Global Ibuprofen API Market Size & CAGR (2026-2033)

North America (Application, Formulation Type)
- US
- Canada
Europe (Application, Formulation Type)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Application, Formulation Type)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Application, Formulation Type)
- Brazil
- Rest of Latin America
Middle East & Africa (Application, Formulation Type)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

BASF SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IOL Chemicals and Pharmaceuticals Limited (IOLCP) (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shandong Xinhua Pharmaceutical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Solara Active Pharma Sciences Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SI Group, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dr. Reddy's Laboratories Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Granules India Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Strides Pharma Science Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOCAUSE Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mallinckrodt Pharmaceuticals (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SMS Pharmaceuticals Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wanbury Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aurobindo Pharma Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zhejiang Huahai Pharmaceutical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jubilant Life Sciences Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments